Monday, February 06, 2023 11:38:36 AM
" There is unmet need for all tumor types. Question is are NWBO results real after all the bias built into the trial."
Guess you don't understand who the helmet works per your comments.
"Guess you don't know the Optune device -- adhesive patches that are placed on the head, called transducer arrays. No "metal helmet", just adhesive fabric."
The helmet incorporates multiple transducers
https://www.med.unc.edu/neurosurgery/new-wearable-device-uses-electric-fields-to-treat-glioblastomas/
"Wearable Device to Treat Brain Cancer by Using Electrical Stimulation"
THERE ARE MANY SIDE EFFECTS
https://www.verywellhealth.com/optune-5072947
Device: Optune®
Optune® is a commercial, portable, battery-operated device intended for continuous home use, which delivers TTFields at a frequency of 200kHz to the brain by means of insulated transducer arrays. The Optune® device produces electric forces intended to disrupt cancer cell division.
https://clinicaltrials.gov/ct2/show/NCT04471844
The good news is that Dr. Linda Liau will "teach up to 1,000 SNO-EANO neurologists, neuro-oncologists, oncologists, neurosurgeons & other KOLs in the US & Europe about the $NWBO #DCVax-L Phase 3 trial results on 2/14/23 (Valentine’s Day):"
Source: ATLnsider, POST # 565093, Sunday, February 05, 2023 5:10:16 PM
https://neuro-onc-academy.org/content/highlights-sno-eano-2022-annual-meetings#group-tabs-node-course-default2
Per H-G comments,
"Optune is approved, DCVax-L isn't, so until it gets approved if it does, Optune is the most efficacious choice."
Many are praying for DCVax-L to be approved and with near zero side effects, perhaps the time is near that the helmet will take a back seat to DCVax-L, IMPO.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
